Cargando…
Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822855/ https://www.ncbi.nlm.nih.gov/pubmed/31154628 http://dx.doi.org/10.1007/s12325-019-00993-8 |
| _version_ | 1783464423104446464 |
|---|---|
| author | Pollock, Richard F. Muduma, Gorden |
| author_facet | Pollock, Richard F. Muduma, Gorden |
| author_sort | Pollock, Richard F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6822855 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68228552019-11-06 Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark Pollock, Richard F. Muduma, Gorden Adv Ther Letter Springer Healthcare 2019-06-01 2019 /pmc/articles/PMC6822855/ /pubmed/31154628 http://dx.doi.org/10.1007/s12325-019-00993-8 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Letter Pollock, Richard F. Muduma, Gorden Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark |
| title | Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark |
| title_full | Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark |
| title_fullStr | Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark |
| title_full_unstemmed | Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark |
| title_short | Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark |
| title_sort | response: an economic evaluation of iron isomaltoside 1000 versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anemia in denmark |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822855/ https://www.ncbi.nlm.nih.gov/pubmed/31154628 http://dx.doi.org/10.1007/s12325-019-00993-8 |
| work_keys_str_mv | AT pollockrichardf responseaneconomicevaluationofironisomaltoside1000versusferriccarboxymaltoseinpatientswithinflammatoryboweldiseaseandirondeficiencyanemiaindenmark AT mudumagorden responseaneconomicevaluationofironisomaltoside1000versusferriccarboxymaltoseinpatientswithinflammatoryboweldiseaseandirondeficiencyanemiaindenmark |